(Q37833102)

24 August 2017

1 reference

title

Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays (English)

1 reference

antiphospholipid syndrome

24 August 2017

1 reference

1 reference

1

Emmanuel J Favaloro

1 reference

24 August 2017

Richard C W Wong

2

1 reference

24 August 2017

publication date

31 January 2011

1 reference

Clinical Chemistry and Laboratory Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

49

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

447-461

1 reference

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Hughes Syndrome: the antiphospholipid syndrome--a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Immunology of the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Clinical features, diagnosis, and management of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Thrombosis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Antiphospholipid syndrome: endocrinologic manifestations and organ involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Neurologic symptoms as a feature of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Antiprothrombin antibody testing: detection and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Twenty-two years of failure to set up undisputed assays to detect patients with the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Laboratory testing for lupus anticoagulants: pre-examination variables, mixing studies, and diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Laboratory testing for lupus anticoagulants: diagnostic criteria and use of screening, mixing, and confirmatory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Standardization, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits, and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Pediatric antiphospholipid antibodies and antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.064

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.064

1 reference

24 August 2017

1 reference